Compound information
- Natural Products
- ZC1231643
- Molecular Formula
- C17H22O5
- Molecular Weight
- 306.146723804 g/mol
- Structure
-
- IUPAC Name
- methyl (E)-3-[4-(3,3-dimethyl-2-oxo-butoxy)-3-methoxy-phenyl]prop-2-enoate
- InChI
- InChI=1S/C17H22O5/c1-17(2,3)15(18)11-22-13-8-6-12(10-14(13)20-4)7-9-16(19)21-5/h6-10H,11H2,1-5H3/b9-7+
- InChI Key
- AUWKTXHXOWGWNZ-VQHVLOKHSA-N
- SMILES
- COC(=O)/C=C/c1ccc(OCC(=O)C(C)(C)C)c(OC)c1
- Source
- ZINC000058157206
Warheads
- Carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 22 | Ring Count | 1 |
Heteroatom Count | 5 | Rotatable Bond Count | 6 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 61.83 Å2 | LogP | 2.826 |
LogS | -4.31 | LogD | 2.908 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.108 | Pgp substrate | 0.983 |
HIA | 0.959 | F20 % | 0.992 |
F30 % | 0.949 | Caco-2 | -4.621 |
MDCK | -4.667 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.252 | PPB | 82.666 |
VD | 0.848 | Fu | 0.515 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.993 | CYP1A2 substrate | 0.417 |
CYP2A6 substrate | 0.624 | CYP2B6 substrate | 0.633 |
CYP2C19 inhibitor | 0.39 | CYP2C19 substrate | 0.659 |
CYP2C8 substrate | 0.623 | CYP2C9 inhibitor | 0.132 |
CYP2C9 substrate | 0.958 | CYP2D6 inhibitor | 0.314 |
CYP2D6 substrate | 0.425 | CYP2E1 substrate | 0.386 |
CYP3A4 inhibitor | 0.034 | CYP3A4 substrate | 0.641 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.956 | CL | 11.524 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.012 | Hepatotoxicity | 0.947 |
Mutagenicity | 0.002 | Rat Oral Acute Toxicity | 0.008 |
FDAMDD | 0.771 | Skin Sensitization | 0.975 |
Carcinogenicity | 0.416 | Eye Corrosion | 0.003 |
Eye Irritation | 0.551 | Respiratory Toxicity | 0.335 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 1.442 | IGC50 | 4.039 |
LC50FM | 5.256 | LC50DM | 5.824 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.33 | NR-AR-LBD | 0.457 |
NR-AhR | 0.195 | NR-Aromatase | 0.315 |
NR-ER | 0.841 | NR-ER-LBD | 0.609 |
NR-PPAR-gamma | 0.552 | SR-ARE | 0.494 |
SR-ATAD5 | 0.788 | SR-HSE | 0.336 |
SR-MMP | 0.584 | SR-p53 | 0.258 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.